Novonesis B ADR (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 4,703,909 | 4,148,230 | 2,598,935 | 2,485,505 | 2,378,704 |
| Cost of Goods | 2,167,875 | 2,190,170 | 1,187,300 | 1,129,402 | 1,006,785 |
| Gross Profit | 2,536,033 | 1,958,060 | 1,411,634 | 1,356,103 | 1,371,919 |
| Operating Expenses | 1,612,894 | 1,416,098 | 834,620 | 710,667 | 735,191 |
| Operating Income | 924,014 | 542,132 | 577,315 | 645,838 | 637,514 |
| Interest Expense | 115,629 | 116,109 | 48,061 | 75,190 | 40,252 |
| Other Income | 32,698 | 25,321 | 38,333 | 74,482 | 27,047 |
| Pre-tax Income | 841,083 | 451,344 | 567,587 | 645,130 | 624,308 |
| Income Tax | 180,798 | 120,438 | 126,324 | 123,192 | 123,939 |
| Net Income Continuous | 660,285 | 330,906 | 441,263 | 521,938 | 500,370 |
| Minority Interests | N/A | N/A | 2,178 | 1,416 | -159 |
| Net Income | $660,285 | $330,906 | $439,085 | $520,522 | $500,529 |
| EPS Basic Total Ops | 1.41 | 0.73 | 1.59 | 1.88 | 1.80 |
| EPS Basic Continuous Ops | 1.42 | 0.72 | 1.59 | 1.89 | 1.80 |
| EPS Diluted Total Ops | 1.41 | 0.73 | 1.58 | 1.87 | 1.79 |
| EPS Diluted Continuous Ops | 1.41 | 0.72 | 1.59 | 1.87 | 1.79 |
| EPS Diluted Before Non-Recurring Items | 1.69 | 1.88 | 1.58 | 1.87 | 1.79 |
| EBITDA(a) | $924,014 | $542,132 | $577,315 | $645,838 | $637,514 |